Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN\SULBACTAM vs AMPRENAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN\SULBACTAM vs AMPRENAVIR: Safety Overview

Metric AMPICILLIN\SULBACTAM AMPRENAVIR
Total FAERS Reports 1,655 109
Deaths Reported 308 4
Death Rate 18.6% 3.7%
Hospitalizations 791 16
Average Patient Age 55.5 yrs 44.0 yrs
% Female Patients 45.5% 25.0%
FDA Approval Date N/A Apr 15, 1999
Marketing Status N/A Discontinued